Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.60
Bid: 9.62
Ask: 10.08
Change: -0.20 (-2.04%)
Spread: 0.46 (4.782%)
Open: 9.60
High: 9.60
Low: 9.60
Prev. Close: 9.80
BVA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AT1 Issuance

17 May 2017 07:00

RNS Number : 3505F
Banco Bilbao Vizcaya Argentaria SA
16 May 2017
 

 

 

 

 

 

Banco Bilbao Vizcaya Argentaria, S.A. ("BBVA"), in compliance with the Securities Market legislation, hereby proceeds by means of the present document to notify the following:

 

 

RELEVANT INFORMATION

 

 

BBVA has agreed to carry out an issue of contingent preferred securities convertible into newly issued ordinary shares of BBVA (the "Preferred Securities"), with exclusion of pre-emptive subscription rights for shareholders, for a total nominal amount of 500 million Euros (the "Issuance").

 

BBVA will request that the Preferred Securities qualify as Additional Tier 1 Capital pursuant to Law 10/2014, of 26 June, on regulation, supervision and solvency of credit entities, and Regulation (EU) No. 575/2013 of the European Parliament and of the Council of 26 June 2013, on prudential requirements for credit institutions and investment firms.

 

The Issuance is targeted only at qualified investors and in any case will not be offered to, and may not be subscribed for, in Spain or by Spanish residents, without prejudice to the additional sales restrictions set out in the terms and conditions of the Issuance.

 

Application has been made to the Irish Stock Exchange plc for the Preferred Securities to be admitted to the Official List and trading on the Global Exchange Market of the Irish Stock Exchange plc.

 

Furthermore, BBVA informs that, for the purposes set out in articles 414, 417 and 511 of the Corporate Enterprises Act, the director's report and the report of the independent expert/auditor of accounts different from the Company's auditor have been issued. These reports have been made available to shareholders through their publication on BBVA's website (www.bbva.com) and will be reported to the first General Shareholders' Meeting to be held after the Issuance.

 

 

 

 

Madrid, 16 May 2017

 

 

Important information:

This announcement does not constitute or form part of an offer of securities for sale in the United States or any other jurisdiction. The Preferred Securities have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") and may not be offered or sold in the United States absent registration or an exemption from the registration requirements of the Securities Act. No money, securities or other consideration from any person inside the United States is being solicited and, if sent in response to the information contained in this announcement, will not be accepted. Further restrictions apply in, among other jurisdictions, the United Kingdom, Spain, Singapore, Hong Kong, Canada and Switzerland, as set out in the offering documentation.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCOKADKCBKDCPD
Date   Source Headline
17th Dec 20181:03 pmRNSPublication of approved ECP Information Memorandum
28th Nov 20185:17 pmRNSComposition of the Board of Directors
5th Nov 20187:00 amRNS2018 Stress Test by European Banking Authority
30th Oct 20187:00 amRNS3Q18 Results Press Release
30th Oct 20187:00 amRNS3Q18 Results Presentation
30th Oct 20187:00 amRNS3Q18 Results Report
22nd Oct 20185:15 pmRNS3rd Quarter Results Presentation Announcement
10th Oct 20185:09 pmRNSTransfer of Real Estate business to Cerberus
27th Sep 20187:00 amRNSDividend October 2018
26th Sep 20183:43 pmRNSOrganizational Changes
18th Sep 20186:17 pmRNSIssue of preferred securities contingently conv.
18th Sep 20188:38 amRNSOffer of securities contingently convertible
30th Jul 20185:00 pmRNSInterim Report BBVA Group June 2018
27th Jul 20187:00 amRNS2Q18 Results Report
27th Jul 20187:00 amRNS2Q18 Results Press Release
27th Jul 20187:00 amRNS2Q18 Results Presentation
23rd Jul 20185:49 pmRNS2Q18 Results Presentation Announcement
9th Jul 20187:00 amRNScompleted sale of its shareholding stake in Chile
27th Jun 20186:20 pmRNSChanges on Board's Committees
4th Jun 20188:26 amRNSSupplemental to the Offering Circular - GMTN
1st Jun 201811:52 amRNSInterim Consolidated Financial Statements
1st Jun 201811:39 amRNSPost Stabilisation Notice
31st May 201812:08 pmRNSMoody's upgrades BBVA's rating
29th May 20184:39 pmRNSGMTN Programme - Final Terms
23rd May 20185:40 pmRNSMREL Requirement
3rd May 201811:12 amRNSPre Stabilisation Notice
30th Apr 20184:58 pmRNSSupplement to the Offering Circular - GMTN
30th Apr 20188:20 amRNS2017 Audited Financial Statements
27th Apr 20187:00 amRNS1Q18 Results Presentation
27th Apr 20187:00 amRNS1Q18 Results Press Release
27th Apr 20187:00 amRNS1Q18 Results Report
26th Apr 20181:06 pmRNS2017 Form 20-F
25th Apr 20184:23 pmRNSSupplement to the Offering Circular - Green Bonds
23rd Apr 20187:40 amRNS1Q18 Results Presentation Announcement
12th Apr 20186:28 pmRNSDBRS upgrades BBVA's rating
9th Apr 201810:11 amRNSPost-Stabilisation Notice - BBVA
9th Apr 20188:25 amRNSS&P upgrades BBVA's rating
16th Mar 20183:45 pmRNSAgreements of shareholders general meetings
13th Mar 20187:00 amRNSEarly expiration
12th Mar 201812:19 pmRNSGMTN Programme
27th Feb 20188:18 amRNSPre-Stabilisation Notice - BBVA
16th Feb 20184:00 pmRNSNew translation of the 2018 AGM agenda
14th Feb 20183:05 pmRNSGMTN Programme-Supplement to the Offering Circular
14th Feb 20189:23 amRNSBBVA Group Annual Report 2017
14th Feb 20187:41 amRNS2018 AGM Proposed Resolutions
13th Feb 20187:00 amRNS2018 Annual General Meeting Call
13th Feb 20187:00 amRNSFinal Dividend Calendar 2017
7th Feb 20182:14 pmRNSPublication of approved ECP Supplement
1st Feb 20187:09 amRNS4Q17 Results Presentation
1st Feb 20187:04 amRNS4Q17 Results Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.